e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Physiology of human pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparing cardiac magnetic resonance imaging in group 1 and group 4 pulmonary hypertension
S. Hoette, N. Creuze, D. Musset, X. Jais, L. Savale, D. Natali, S. Gunther, O. Sitbon, G. Simonneau, M. Humbert, D. Chemla (Clamart, France)
Source:
Annual Congress 2011 - Physiology of human pulmonary hypertension
Session:
Physiology of human pulmonary hypertension
Session type:
Thematic Poster Session
Number:
2309
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hoette, N. Creuze, D. Musset, X. Jais, L. Savale, D. Natali, S. Gunther, O. Sitbon, G. Simonneau, M. Humbert, D. Chemla (Clamart, France). Comparing cardiac magnetic resonance imaging in group 1 and group 4 pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 2309
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting?
Source: Eur Respir Rev, 29 (156) 200139; 10.1183/16000617.0139-2020
Year: 2020
Cardiac magnetic resonance imaging in pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 526-534
Year: 2013
A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension
Source: Eur Respir J 2009; 33: 1454-1466
Year: 2009
Cardiac magnetic resonance imaging versus echocardiography for assessment of cardiac involvement in pulmonary sarcoidosis
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Acute changes to sildenafil in pulmonary arterial hypertension assessed by magnetic resonance imaging
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Clinical evaluation of RV wall stress in pulmonary arterial hypertension: A follow-up study using magnetic resonance imaging
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Dynamic oxygen-enhanced magnetic resonance imaging-based quantification of pulmonary hypertension
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Three dimensional (3D) analysis of septal curvature from cardiac magnetic resonance images to determine pulmonary hypertension severity
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Effects of treatment for pulmonary hypertension on pulmonary artery distensibility determined by cardiac magnetic resonance imaging
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension
Source: Eur Respir Rev, 29 (156) 190138; 10.1183/16000617.0138-2019
Year: 2020
Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018
Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF)
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010
Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure
Source: Eur Respir J 2002; 20: 1519-1524
Year: 2002
The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Right ventricular interaction in pulmonary arterial hypertension
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008
Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema
Source: Eur Respir J 2002; 19: 225-231
Year: 2002
Imaging of pulmonary pathologies: focus on magnetic resonance imaging
Source: Annual Congress 2010 - PG2 Core Curriculum Postgraduate Course: Breaking news on imaging in critically ill patients
Year: 2010
Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept